Menu Search
Equities

Pihlajalinna Oyj

38P:MUN

Pihlajalinna Oyj

Actions
  • Price (EUR)8.98
  • Today's Change0.00 / 0.00%
  • Shares traded-1.00
  • 1 Year change-4.47%
  • Beta--
Data delayed at least 15 minutes, as of May 16 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Pihlajalinna Oyj is a Finland-based company providing social and healthcare services. It dedicates its offer to individuals, businesses and public institutions. It operates medical and health centers, dental clinics and hospitals around Finland. The Company operates in two segments: Private Clinics and Specialized Care (L&E), which includes medical centers, surgical operations, public specialized care, dental healthcare and occupational health services; and Primary and Social Care (P&S), which comprises social care, outsourcing of healthcare, health packages, and employment services. The Company's activities are conducted under two brands, namely Pihlajalinna and Dextra. Also, it offers wellbeing services through the Forever fitness centre chain.

  • Revenue in EUR (TTM)715.38m
  • Net income in EUR7.43m
  • Incorporated2014
  • Employees6.72k
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.